Windlas Biotech vs Nifty 50: Share Price Performance Compared
- October 13, 2026
- Posted by: Kunal Singla
- Category: Market
Windlas Biotech share price Rs 949.20 on NSE. Windlas Biotech vs Nifty 50 over 1 year: +4.06% vs -11.35%. 52-week high Rs 1,181.90, low Rs 697.40.
Quick Answer
Windlas Biotech vs Nifty 50 gives a mixed picture: Windlas Biotech has beaten the index in 4 of 5 time frames, and its 1-year return of +4.06% compares with -11.35% for the Nifty 50. Over three years, Windlas Biotech gained 156.09% while the Nifty 50 gained 13.23%, a gap of 142.86 percentage points in its favour. At Rs 949.20, Windlas Biotech is 19.7% below its 52-week high of Rs 1,181.90 and 36.1% above its 52-week low of Rs 697.40. Returns use NSE closing prices to 12 October 2026, and past performance does not indicate future results.
Windlas Biotech vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Windlas Biotech trades on the NSE under the symbol WINDLAS, and its 1-month return of -15.94% compares with -4.42% for the Nifty 50 over the same period.
The Windlas Biotech vs Nifty 50 comparison matters because Windlas Biotech is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Windlas Biotech share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data up to 12 October 2026.
Also read – Wonderla Holidays vs Nifty 50: Share Price Performance Compared
Click Here – Get Free Investment Predictions
Windlas Biotech vs Nifty 50: Performance at a Glance
The table below sets out the Windlas Biotech vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 12 October 2026.
| Time Frame | Windlas Biotech Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | -15.94% | -4.42% | -11.52 pp |
| 3 Months | +11.38% | -7.63% | +19.01 pp |
| 6 Months | +16.58% | -6.20% | +22.78 pp |
| 1 Year | +4.06% | -11.35% | +15.41 pp |
| 3 Years | +156.09% | +13.23% | +142.86 pp |
On the Windlas Biotech vs Nifty 50 scorecard, Windlas Biotech has beaten the index over the latest 1-year window, returning +4.06% against -11.35% for the Nifty 50, a difference of 15.41 percentage points. The widest gap on the table is over three years, where Windlas Biotech gained 156.09% while the Nifty 50 gained 13.23%, a difference of 142.86 percentage points in favour of the stock. The direction differs over the past year: Windlas Biotech moved up while the Nifty 50 moved down.
Check the Univest Screener for live Windlas Biotech and Nifty 50 data
Latest Close and 52-Week Range: Windlas Biotech and the Nifty 50
| Instrument | Latest Close | 52-Week High | 52-Week Low | Vs 52-Week High |
|---|---|---|---|---|
| Windlas Biotech | Rs 949.20 | Rs 1,181.90 | Rs 697.40 | -19.7% |
| Nifty 50 | 22,363.35 | 26,373.20 | 22,179.90 | -15.2% |
Windlas Biotech closed at Rs 949.20 on 12 October 2026, which is 19.7% below its 52-week high of Rs 1,181.90 and 36.1% above its 52-week low of Rs 697.40. The Nifty 50 closed at 22,363.35, 15.2% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.
Why the Windlas Biotech vs Nifty 50 Gap Exists
Windlas Biotech can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Windlas Biotech has traded between Rs 697.40 and Rs 1,181.90, a spread of 69.5% from low to high, against 18.9% for the Nifty 50.
Trading depth also shapes the Windlas Biotech vs Nifty 50 gap. Stocks with a smaller trading base tend to react more to a single result, block deal or news item than the diversified Nifty 50 does, and Windlas Biotech is judged on its own record rather than on an average.
Download the Univest iOS App or Univest Android App to track Windlas Biotech and Nifty 50 live on the go.
Windlas Biotech vs Nifty 50: Has Windlas Biotech Beaten the Benchmark?
Yes, over the past year. Windlas Biotech returned +4.06% against -11.35% for the Nifty 50, a lead of 15.41 percentage points. Across the five time frames measured, Windlas Biotech is ahead of the index over 3 months, 6 months, 1 year and 3 years and behind it over 1 month.
Risks of the Windlas Biotech vs Nifty 50 Comparison
Reading too much into a Windlas Biotech vs Nifty 50 comparison has real limitations. Point-to-point returns depend entirely on the start date chosen, so a stock that looks ahead of the index over one window can look behind over the next, and none of these figures predicts future returns.
Also read – Xpro India vs Nifty 50: Share Price Performance Compared
Windlas Biotech carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 697.40 to Rs 1,181.90 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.
Conclusion
Windlas Biotech vs Nifty 50 shows Windlas Biotech ahead of the index in 4 of 5 time frames and behind in the rest, which is why the answer depends on the horizon an investor cares about. Volatility, liquidity and sector concentration deserve as much weight as the return history, and a SEBI-registered advisor can help fit Windlas Biotech into a wider portfolio.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Windlas Biotech outperformed the Nifty 50 in the last year?
Ans. Yes. Windlas Biotech returned +4.06% over the past year while the Nifty 50 returned -11.35%, based on NSE closing prices to 12 October 2026.
How does Windlas Biotech vs Nifty 50 look over 3 years?
Ans. Over three years Windlas Biotech has returned +156.09% compared with the Nifty 50’s +13.23%, so in the Windlas Biotech vs Nifty 50 comparison the stock has been ahead over this horizon.
What is the Windlas Biotech share price today compared to Nifty 50?
Ans. Windlas Biotech share price closed at Rs 949.20 on NSE on 12 October 2026, while the Nifty 50 closed at 22,363.35 in the same session.
What is the 52-week high and low of Windlas Biotech?
Ans. Windlas Biotech’s 52-week high is Rs 1,181.90 and its 52-week low is Rs 697.40, based on NSE data. The latest close of Rs 949.20 is 19.7% below the high.
Why does Windlas Biotech show bigger price swings than the Nifty 50?
Ans. Windlas Biotech carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Windlas Biotech has traded in a 69.5% low-to-high range against 18.9% for the index, a key reason the Windlas Biotech vs Nifty 50 return gap varies across time frames.
Is Windlas Biotech a good long-term investment compared to a Nifty 50 index fund?
Ans. Windlas Biotech’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Windlas Biotech vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.
